On May 23, 2023, Ventyx Biosciences Inc. (NASDAQ: VTYX) opened at $35.41, higher 2.05% from the last session. During the day, the shares moved up to $37.17 and dropped to $35.135 before settling in for the closing price of $35.55. Price fluctuations for VTYX have ranged from $11.07 to $47.25 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -22.10% at the time writing. With a float of $54.22 million, this company’s outstanding shares have now reached $57.64 million.
Let’s look at the performance matrix of the company that is accounted for 76 employees.
Ventyx Biosciences Inc. (VTYX) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ventyx Biosciences Inc. is 3.80%, while institutional ownership is 99.70%. The most recent insider transaction that took place on May 15, was worth 127,182. In this transaction the insider of this company sold 3,487 shares at a rate of $36.47, taking the stock ownership to the 34,662 shares. Before that another transaction happened on May 05, when Company’s Chief Executive Officer sold 30,000 for $39.28, making the entire transaction worth $1,178,502. This insider now owns 1,543,126 shares in total.
Ventyx Biosciences Inc. (VTYX) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 3/30/2023, the company posted -$0.68 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.65) by -$0.03. This company achieved a return on equity of -34.25. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.73 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -22.10% per share during the next fiscal year.
Ventyx Biosciences Inc. (NASDAQ: VTYX) Trading Performance Indicators
Check out the current performance indicators for Ventyx Biosciences Inc. (VTYX). In the past quarter, the stock posted a quick ratio of 23.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.28, a number that is poised to hit -0.71 in the next quarter and is forecasted to reach -3.17 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc. (VTYX)
Ventyx Biosciences Inc. (NASDAQ: VTYX) saw its 5-day average volume 0.7 million, a negative change from its year-to-date volume of 0.8 million. As of the previous 9 days, the stock’s Stochastic %D was 36.98%. Additionally, its Average True Range was 1.97.
During the past 100 days, Ventyx Biosciences Inc.’s (VTYX) raw stochastic average was set at 43.74%, which indicates a significant decrease from 48.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.30% in the past 14 days, which was lower than the 59.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $35.43, while its 200-day Moving Average is $32.95. Nevertheless, the first resistance level for the watch stands at $37.25 in the near term. At $38.23, the stock is likely to face the second major resistance level. The third major resistance level sits at $39.29. If the price goes on to break the first support level at $35.22, it is likely to go to the next support level at $34.16. Assuming the price breaks the second support level, the third support level stands at $33.18.
Ventyx Biosciences Inc. (NASDAQ: VTYX) Key Stats
There are currently 58,350K shares outstanding in the company with a market cap of 2.06 billion. Presently, the company’s annual sales total 0 K according to its annual income of -108,430 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -38,930 K.
